Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
MT-1 (Afamelanotide) has been studied and approved in some countries for the treatment of erythropoietic protoporphyria (EPP), a rare disorder that causes severe sensitivity to light
Patients in this group typically observe hair density and texture improvements after their first complete cycle
D.RyanT.PienkowskiT.LaRockR.QuanderR.et al (2015)
People seeking beauty supplements
The more serious side effects are complex gastrointestinal (GI) issues, vision loss, and DVT
US$ 20.69
US$ 25.86
US$ 28.38
